from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1458c/-

LFCtreatmentdescriptionclass of inhibitor

-2.181

Amikacinug/mL Amikacintranslation

-1.366

Cap5-10ug/mL Capreomycintranslation

-2.405

Rox10-50 ug/mL Roxithromycintranslation

-0.068

SM2-5 ug/mL Streptomycintranslation

-2.979

Tet5-10 ug/mL Tetracyclinetranslation

-0.745

Rif0.2-5ug/mL Rifampicintranscription

-0.145

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.319

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.784

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.094

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.454

Clofazimine10-13 ug/mL Clofaziminerespiration

0.751

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.322

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.437

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.213

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.111

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.253

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.874

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.205

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.147

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.725

KCN5-20 ug/mL Potassium cyaniderespiration

-0.378

NaN30.2-2 mM Sodium aziderespiration

-0.903

Nigericin50 uM Nigericinrespiration

0.633

TRC10-150 ug/mL Triclosanrespiration

0.111

TRZ10-25 ug/mL Thioridazinerespiration

-0.654

Valinomycin0.5-10 uM Valinomycinrespiration

0.627

ZnSO42 mM ZnSO4respiration

-0.380

menadione6-10 ug/mL Menadionerespiration

0.532

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.711

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.395

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.802

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.067

NRP_1Non-replicating persistence stage 1dosRassociated

0.323

Amp0.2mg/mL AmpicillincellWall

0.337

Cephalexin20-100 ug/mL CephalexincellWall

0.684

Cerulenin0.32-5 ug/mL CerulenincellWall

0.420

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.298

EMB10-20 ug/mL EthambutolcellWall

-0.129

Eta12-40 ug/mL EthionamidecellWall

-0.863

INH0.2-0.4 ug/mL IsoniazidcellWall

0.610

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.083

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.584

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.063

BZA0.12 mg/mL BenzamidearomaticAmides

-0.185

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.310

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.390

H2O24 mM hydrogen peroxideDNAdamaging

0.857

Levo10 ug/mL LevofloxacinDNAdamaging

0.536

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.120

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.335

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.555

UVUV-irradiationDNAdamaging

-1.042

ARP41-4 ug/mL Antitubercular compound ARP4?

0.468

Antimycin12.5-50 ug/mL Antimycin A?

-0.064

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.876

PA_110-50 ug/mL Antitubercular compound PA-1?

0.999

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.995

PA8240.2-2 ug/mL PA-824?

-0.909

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.018

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.123

Verapamil50 uM Verapamil?

0.373

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.662

methoxatin10-20 ug/mL Methoxatin?